Elhalwagy A

No ORCID on file · 1 paper in corpus
2017
Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study.
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2017.44.4.232

ObjectiveTo determine whether reducing the cetrorelix dose in the antagonist protocol to 0.125 mg had any deleterious effects on follicular development, the number and quality of retrieved oocytes, or the number of embryos, and to character…